BioMarin Pharmaceutical Cash on Hand 2006-2020 | BMRN

BioMarin Pharmaceutical cash on hand from 2006 to 2020. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • BioMarin Pharmaceutical cash on hand for the quarter ending March 31, 2020 was $0.858B, a 4.07% decline year-over-year.
  • BioMarin Pharmaceutical cash on hand for 2019 was $0.754B, a 30.48% decline from 2018.
  • BioMarin Pharmaceutical cash on hand for 2018 was $1.084B, a 22.33% decline from 2017.
  • BioMarin Pharmaceutical cash on hand for 2017 was $1.396B, a 76.78% increase from 2016.
BioMarin Pharmaceutical Annual Cash on Hand
(Millions of US $)
2019 $754
2018 $1,084
2017 $1,396
2016 $790
2015 $593
2014 $945
2013 $785
2012 $448
2011 $195
2010 $274
2009 $301
2008 $560
2007 $586
2006 $289
2005 $48
BioMarin Pharmaceutical Quarterly Cash on Hand
(Millions of US $)
2020-03-31 $858
2019-12-31 $754
2019-09-30 $721
2019-06-30 $731
2019-03-31 $895
2018-12-31 $1,084
2018-09-30 $1,443
2018-06-30 $1,363
2018-03-31 $1,383
2017-12-31 $1,396
2017-09-30 $1,257
2017-06-30 $728
2017-03-31 $678
2016-12-31 $790
2016-09-30 $1,035
2016-06-30 $503
2016-03-31 $457
2015-12-31 $593
2015-09-30 $618
2015-06-30 $682
2015-03-31 $1,009
2014-12-31 $945
2014-09-30 $666
2014-06-30 $837
2014-03-31 $887
2013-12-31 $785
2013-09-30 $380
2013-06-30 $401
2013-03-31 $402
2012-12-31 $448
2012-09-30 $426
2012-06-30 $403
2012-03-31 $233
2011-12-31 $195
2011-09-30 $224
2011-06-30 $259
2011-03-31 $253
2010-12-31 $274
2010-09-30 $352
2010-06-30 $338
2010-03-31 $324
2009-12-31 $301
2009-09-30 $363
2009-06-30 $346
2009-03-31 $552
2008-12-31 $560
2008-09-30 $563
2008-06-30 $576
2008-03-31 $575
2007-12-31 $586
2007-09-30 $587
2007-06-30 $588
2007-03-31 $273
2006-12-31 $289
2006-09-30 $294
2006-06-30 $306
2006-03-31 $348
2005-12-31 $48
2005-09-30 $66
2005-06-30 $27
2005-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $23.279B $1.704B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.997B 16.30
Bristol Myers Squibb (BMY) United States $134.766B 11.26
Gilead Sciences (GILD) United States $94.843B 12.29
CSL (CSLLY) Australia $89.938B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.725B 52.75
Regeneron Pharmaceuticals (REGN) United States $70.449B 27.16
Illumina (ILMN) United States $54.371B 55.87
Biogen (BIIB) United States $45.724B 7.83
Seattle Genetics (SGEN) United States $30.385B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.849B 10.25
Incyte (INCY) United States $23.535B 0.00
Genmab (GMAB) Denmark $23.005B 18.95
Moderna (MRNA) United States $22.860B 0.00
Genmab (GNMSF) Denmark $21.647B 64.27
Alnylam Pharmaceuticals (ALNY) United States $18.506B 0.00
BeiGene (BGNE) Cayman Islands $15.873B 0.00
BioNTech SE (BNTX) Germany $15.286B 0.00
Exact Sciences (EXAS) United States $13.742B 0.00
Sarepta Therapeutics (SRPT) United States $13.270B 0.00
Galapagos (GLPG) Belgium $13.081B 38.48
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.817B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.210B 27.59
Bio-Techne Corp (TECH) United States $10.473B 69.19
QIAGEN (QGEN) Netherlands $9.923B 28.85
Immunomedics (IMMU) United States $9.594B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.791B 0.00
Guardant Health (GH) United States $8.241B 0.00
Exelixis (EXEL) United States $7.334B 25.72
Ascendis Pharma (ASND) Denmark $6.971B 0.00
Repligen (RGEN) United States $6.553B 114.94
Adaptive Biotechnologies (ADPT) United States $6.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.835B 125.56
Novavax (NVAX) United States $5.697B 0.00
Acceleron Pharma (XLRN) United States $5.505B 0.00
Vir Biotechnology (VIR) United States $5.432B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.369B 0.00
Reata Pharmaceuticals (RETA) United States $5.251B 0.00
Mirati Therapeutics (MRTX) United States $5.193B 0.00
Zai Lab (ZLAB) China $5.048B 0.00
Emergent Biosolutions (EBS) United States $4.950B 32.44
MyoKardia (MYOK) United States $4.448B 0.00
MorphoSys AG (MOR) Germany $4.393B 34.07
Blueprint Medicines (BPMC) United States $4.263B 0.00
China Biologic Products (CBPO) China $4.244B 23.59
Global Blood Therapeutics (GBT) United States $4.165B 0.00
Amicus Therapeutics (FOLD) United States $4.066B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.061B 0.00
Halozyme Therapeutics (HALO) United States $3.872B 0.00
NeoGenomics (NEO) United States $3.804B 277.77
Inovio Pharmaceuticals (INO) United States $3.709B 0.00
Bluebird Bio (BLUE) United States $3.692B 0.00
Arena Pharmaceuticals (ARNA) United States $3.346B 0.00
Alkermes (ALKS) Ireland $3.239B 63.77
Deciphera Pharmaceuticals (DCPH) United States $3.173B 0.00
Fate Therapeutics (FATE) United States $2.930B 0.00
Insmed (INSM) United States $2.869B 0.00
Denali Therapeutics (DNLI) United States $2.863B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
PHARMA MAR SA (PHMMF) Spain $2.470B 0.00
Twist Bioscience (TWST) United States $2.237B 0.00
Viela Bio (VIE) United States $2.207B 0.00
UniQure (QURE) Netherlands $2.075B 0.00
Alector (ALEC) United States $1.920B 0.00
Editas Medicine (EDIT) United States $1.913B 0.00
Eidos Therapeutics (EIDX) United States $1.898B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Principia Biopharma (PRNB) United States $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 69.98
Forma Therapeutics Holdings (FMTX) United States $1.741B 0.00
Adverum Biotechnologies (ADVM) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.698B 0.00
I-Mab (IMAB) China $1.673B 0.00
Intra-Cellular Therapies (ITCI) United States $1.665B 0.00
Epizyme (EPZM) United States $1.642B 0.00
Cytokineticsorporated (CYTK) United States $1.601B 0.00
Mersana Therapeutics (MRSN) United States $1.530B 0.00
Sorrento Therapeutics (SRNE) United States $1.529B 0.00
Mesoblast (MESO) Australia $1.509B 0.00
Sangamo Therapeutics (SGMO) United States $1.495B 0.00
Beam Therapeutics (BEAM) United States $1.494B 0.00
Revance Therapeutics (RVNC) United States $1.488B 0.00
NantKwest (NK) United States $1.477B 0.00
Zealand Pharma (ZEAL) Denmark $1.469B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.449B 0.00
Akcea Therapeutics (AKCA) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.353B 0.00
Arvinas (ARVN) United States $1.328B 0.00
Intellia Therapeutics (NTLA) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.223B 0.00
Arcus Biosciences (RCUS) United States $1.164B 0.00
Athenex (ATNX) United States $1.091B 0.00
Compugen (CGEN) Israel $1.090B 0.00
Alcobra (ARCT) United States $1.018B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.986B 0.00
VBI Vaccines (VBIV) United States $0.911B 0.00
Retrophin (RTRX) United States $0.899B 0.00
Dynavax Technologies (DVAX) United States $0.868B 0.00
Myriad Genetics (MYGN) United States $0.868B 44.77
Heska (HSKA) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.830B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.775B 0.00
Morphic Holding (MORF) United States $0.766B 0.00
Kadmon Holdings (KDMN) United States $0.752B 0.00
Cellectis S.A (CLLS) France $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.735B 0.00
Castle Biosciences (CSTL) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.708B 0.00
Vericel (VCEL) United States $0.686B 126.75
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Cue Biopharma (CUE) United States $0.670B 0.00
Agenus (AGEN) United States $0.658B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.41
AnaptysBio (ANAB) United States $0.621B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.591B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.566B 0.00
Athersys (ATHX) United States $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.548B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
NextCure (NXTC) United States $0.512B 0.00
Protagonist Therapeutics (PTGX) United States $0.511B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.506B 0.00
Scholar Rock Holding (SRRK) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.501B 16.12
DBV Technologies S.A (DBVT) France $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.491B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.467B 0.00
MeiraGTx Holdings (MGTX) United States $0.466B 0.00
Geron (GERN) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.443B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Precision BioSciences (DTIL) United States $0.430B 0.00
Seres Therapeutics (MCRB) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 22.47
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.403B 0.00
MannKind (MNKD) United States $0.388B 0.00
CytomX Therapeutics (CTMX) United States $0.385B 0.00
Albireo Pharma (ALBO) United States $0.382B 0.00
Kamada (KMDA) Israel $0.371B 15.44
Avid Bioservices (CDMO) United States $0.369B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
ANI Pharmaceuticals (ANIP) United States $0.352B 6.97
Affimed (AFMD) Germany $0.349B 0.00
OSMOTICA PHARM (OSMT) United States $0.328B 0.00
Prometic Life Sciences (LMNL) Canada $0.328B 0.00
PDL BioPharma (PDLI) United States $0.324B 284.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Spero Therapeutics (SPRO) United States $0.291B 0.00
Abeona Therapeutics (ABEO) United States $0.286B 0.00
Menlo Therapeutics (MNLO) United States $0.285B 0.00
Pfenex (PFNX) United States $0.282B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.275B 0.00
Celldex Therapeutics (CLDX) United States $0.274B 0.00
IBio (IBIO) United States $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
IVERIC Bio (ISEE) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
Verastem (VSTM) United States $0.249B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.238B 0.00
Five Prime Therapeutics (FPRX) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.234B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Aptinyx (APTX) United States $0.218B 0.00
XOMA (XOMA) United States $0.214B 0.00
Liquidia Technologies (LQDA) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 3.11
Sutro Biopharma (STRO) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.185B 0.00
Bellus Health (BLU) Canada $0.179B 0.00
Trevena (TRVN) United States $0.173B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
Cyclerion Therapeutics (CYCN) United States $0.158B 0.00
VTv Therapeutics (VTVT) United States $0.156B 0.00
Cerecor (CERC) United States $0.155B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.135B 0.00
PHASEBIO PHARMA (PHAS) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Oncobiologics (OTLK) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.06
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.109B 0.00
Eton Pharmaceuticals (ETON) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.094B 0.00
Unum Therapeutics (UMRX) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
AnPac Bio-Medical Science (ANPC) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Signal Genetics (MGEN) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Ecology Coatings (ABVC) United States $0.051B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.045B 0.00
Apricus Biosciences (SEEL) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
BioCardia (BCDA) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00